Primary record
(3S,4aS,8aS)-2-[(2R,3R)-2-Hydroxy-3-(3-hydroxy-2-methyl-benzoylamino)-4-phenylsulfanyl-butyl]-decahydro-isoquinoline-3-carboxylic acid tert-butylamide; compound with methanesulfonic acid
- 库存
- 1,704 克
- 纯度
- 98.3 %
- CAS
- 159989-64-7
化合物标识与属性
- CAS
- 159989-64-7
- PubChem CID
- 64143
- SMILES
- CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@@H](CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C)O
- Canonical SMILES
- Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C
名称与同义词
- nelfinavir
- Viracept
- Nelfinavir mesylate
- 159989-64-7
- nelfinavirum
- Viracept (TN)
- Nelfinavir?
- Nelfinavir (INN)
- Nelfinavir [INN:BAN]
- 1ohr
- Nelfinavir mesilate
- HO3OGH5D7I
- Nelfinavir [BAN:INN]
- Nelfinavir (Standard)
- SARS therapy, aRigen
- UNII-HO3OGH5D7I
- CHEMBL584
- NELFINAVIR [MI]
- RefChem:57161
- C32H45N3O4S
- NELFINAVIR [INN]
- AG1343
- NELFINAVIR [VANDF]
- D08ZFL
- D0L3MP
- CHEBI:7496
- VRX496
- AG-1343
- AG1343 (*Mesylate salt*)
- CHEMBL1205
- NELFINAVIR [WHO-DD]
- Nelfinavir Monomethane Sulfonate
- BIDD:PXR0143
- Nelfinavir (SARS infection)
- SCHEMBL38218
- BDBM518
- DTXSID5035080
- Met-SDF-1.beta. & Nelfinavir
- MLS001195634
- MLS001304729
- NELFINAVIR MESYLATE AG1343
- BIDD:GT0395
- NELFINAVIR [EMA EPAR]
- NSC-747167
- Viracept (TM)(*Mesylate salt*)
- AC1L20J6
- ARV-SR0121
- orb1299514
- DTXCID3015080
- nelfinavir & nelfinavir mesylate
- SCHEMBL29359793
- GTPL11090
- J05AE04
- 3-Bromo-1,1,1-trifluoroacetone
- AG1341
- AG1346
- MFCD01938163
- QAGYKUNXZHXKMR-HKWSIXNMSA-N
- GLXC-27474
- HMS2232I04
- AG 1343
- CID64143
- Viracept (SARS infection), aRigen
- ZINC3833846
- BDBM50061306
- C32-H45-N3-O4-S
- EBC-27328
- EX-A15162
- HY-15287R
- MFCD00931436
- Nelfinavir (SARS infection), aRigen
- NSC722664
- NSC747167
- AKOS000280862
- AM84529
- CS-0677
- CS-O-01962
- DB00220
- NSC 747167
- MRF-0000208
- NCGC00090782-03
- NCGC00090782-04
- NCGC00090782-05
- NCGC00090782-17
- AC-20032
- AC-37645
- AN-31040
- AS-75258
- BC216005
- HY-15287
- LS-85417
- SMR000596515
- (3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide
- A3653
- B1122
- FT-0631187
- NS00003195
- J1.642.472B
- 89N647
- C07257
- C73027
- D08259
- AB00698259-15
- A810095
- EN300-18530973
- Q423366
- (3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-(phenylsulfanyl)butyl]-decahydroisoquinoline-3-carboxamide
- BRD-K74117820-066-10-8
- Met-Stromal Cell-derived Factor-1.beta. (Human) & Nelfinavir
- (3S-(2(2S*,3S*),3alpha,4abeta,8abeta))-N-(1,1-Dimethylethyl)decahydro-2-(2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-3-isoquinolinecarboxamide
- 159989-65-8
- 1UN
- 2-[2-HYDROXY-3-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-4-PHENYL SULFANYL-BUTYL]-DECAHYDRO-ISOQUINOLINE-3-CARBOXYLIC ACID TERT-BUTYLAMIDE
- 3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, (3S,4aS,8aS)-
- NFV
- NLF
- (3S,4aS,8aS)-N-(tert-Butyl)-2-((2R,3R)-2-hydroxy-3-(3-hydroxy-2-methylbenzamido)-4-(phenylthio)butyl)decahydroisoquinoline-3-carboxamide
- (3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methyl-benzoyl)amino]-4-phenylsulfanyl-butyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide
- 3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-(2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-, (3S-(2-(2S*,3S*),3-alpha,4a-beta,8a-beta))-
- N-(1,1-Dimethylethyl)decahydro-2-(2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-3-isoquinolinecarboxamide (3S-(2(2S*,3S*),3alpha,4abeta,8abeta))-
- 3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-((2R,3R)-2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-, (3S,4aS,8aS)-
- (3S, 4aS, 8aS)-2-[(2R, 3R)-2-Hydroxy-3-(3-hydroxy-2-methyl-benzoylamino)-4-phenylthiobutyl]decahydroisoquinoline-3-carboxylic acid t-butylamide
- (3S, 4aS, 8aS)-2-[(2R, 3R)-2-hydroxy-3-(3-hydroxy-2-methylbenzoylamino)-4-phenylthiobutyl]decahydroisoquinoline-3-carboxylic acid t-butylamide
- (3S,4abeta,8abeta)-N-tert-Butyl-2-[(2R,3R)-2-hydroxy-3-(2-methyl-3-hydroxybenzoylamino)-4-(phenylthio)butyl]decahydroisoquinoline-3alpha-carboxamide
- (3S,4aS,8aS)-2-[(2R,3R)-2-Hydroxy-3-(3-hydroxy-2-methyl-benzoylamino)-4-phenylsulfanyl-butyl]-decahydro-isoquinoline-3-carboxylic acid tert-butylamide; compound with methanesulfonic acid
- (3S,4aS,8aS)-2-[(2R,3R)-2-hydroxy-3-(3-hydroxy-2-methylbenzoylamino)-4-phenylthiobutyl]decahydroisoquinoline-3-carboxylic acid t-butylamide
- (3S,4aS,8aS)-N-tert-butyl-2-((2R,3R)-2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-phenylsulfanylbutyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide
- (3S,4aS,8aS)-N-tert-Butyl-2-[(2R,3R)-2-hydroxy-3-(3-hydroxy-2-methylbenzamido)-4-(phenylsulfanyl)butyl]decahydroisoquinoline-3-carboxamide
- (3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylsulfanyl)butyl]decahydroisoquinoline-3-carboxamide
- (3S,4aS,8aS)-N-tert-Butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]decahydroisoquinoline-3-carboxamide
- (3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-{[(3-hydroxy-2-methylphenyl)carbonyl]amino}-4-(phenylsulfanyl)butyl]decahydroisoquinoline-3-carboxamide
- 3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2- [(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, (3S,4aS,8aS)-
- 3-Isoquinolinecarboxamide,1-dimethyl ethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, (3S,4aS,8aS)-
- 3-Isoquinolinecarboxamide,1-dimethylethyl)decahydro-2-[2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, [3S-[2(2S*,3S*),3.alpha.,4a.beta.,8a.beta.]]-